Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report
Han Zhang1, Yang Yang2, Xiang Luo1
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China.
Abstract:
Myelin oligodendrocyte glycoprotein (MOG) antibodies have been found in a broad range of demyelination diseases. In the present study, we reported three cases of patients with anti-MOG antibodies associated disorders (MOG-ADs) who initially presented as intracranial infection like encephalomeningitis with no evidence of demyelination injury, but were subsequently found the expression of MOG antibodies and other demyelination presentations. Our findings suggested that MOG-ADs can start as an intracranial infection like prodromal symptoms prior to the lesions of optic nerve, spinal cord, and white matter. Therefore, clinicians should be cautious of MOG-ADs in cases of encephalomeningitis even without demyelination injury.
Insights
Myelin oligodendrocyte glycoprotein antibody-associated disorders can mimic intracranial infections initially. Early recognition is crucial even without initial demyelination signs for timely MOG-AD diagnosis and treatment.
Area of Science:
- Neuroimmunology
- Neurology
- Infectious Diseases
Background:
- Myelin oligodendrocyte glycoprotein (MOG) antibodies are implicated in various demyelinating diseases.
- Distinguishing MOG antibody-associated disorders (MOG-ADs) from other neurological conditions is clinically important.
Observation:
- Three cases presented initially with symptoms resembling intracranial infection, such as encephalomeningitis.
- These patients showed no initial evidence of demyelination on diagnostic imaging.
- Subsequent testing revealed MOG antibodies and other demyelinating manifestations.
Findings:
- MOG-ADs can manifest with prodromal symptoms mimicking intracranial infections.
- The initial presentation may precede overt signs of demyelination in the optic nerve, spinal cord, or white matter.
Implications:
- Clinicians should consider MOG-ADs in patients with encephalomeningitis, even in the absence of demyelination.
- This highlights the importance of MOG antibody testing in atypical neurological presentations.
- Prompt diagnosis can lead to appropriate management and potentially better patient outcomes.
More Related Videos
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology


